Search results
Secondary cancer: Why breast cancer survivors have a higher risk
Medical News Today· 4 days agoHaving had breast cancer increases women’s as well as men’s risk of a second cancer later by around 25%, according to research. In addition, a new study ...
O.J. Simpson's Official Cause Of Death Revealed 2 Weeks After His Passing
The Blast· 3 days agoFootball legend and acquitted murderer O.J. Simpson's official cause of death has finally been...
As Charles announces a return to public-facing duties, a look at recent events involving the royals
San Francisco Chronicle· 2 days agoKing Charles III is on the comeback trail. The 75-year-old British monarch will slowly ease back...
King Charles To Resume Some Public Duties During Cancer Treatment: Palace
International Business Times· 3 days agoBritish head of state King Charles III will make a limited return to public duties next week, after...
As Charles announces a return to public-facing duties, a look at recent events involving the royals
Associated Press via Yahoo News· 2 days agoKing Charles III is on the comeback trail. The 75-year-old British monarch will slowly ease back...
Convicted murderer Katrina Giles gets medical 'furlough'
Herald & Review· 6 days agoA female felon who took park in planning a vicious double murder — and then conspired to provide her...
King Charles to resume some public duties during cancer treatment: palace
Alaska Superstation· 3 days agoBritish head of state King Charles III will make a limited return to public duties next week, after doctors said they were "very encouraged" by the progress of his treatment for cancer ...
Johnson & Johnson (NYSE:JNJ) Shares Down 0.1%
ETF DAILY NEWS· 4 days agoJohnson & Johnson (NYSE:JNJ – Get Free Report) traded down 0.1% during mid-day trading on Tuesday . Raymond James upped their price objective on shares of Johnson & Johnson from $172.00 to $175.00 ...
Council Post: AI Can ‘Unbias’ Healthcare—But Only If We Work Together To End Data Disparity
Forbes· 3 days agoRohit Nambisan is CEO and co-founder at Lokavant, a clinical trial intelligence platform company....